ClinicalTrials.Veeva

Menu
N

Neurology Clinic, P.C. | Cordova, TN

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3002813
Buntanetap
Donanemab
Remternetug
Pitolisant
PF-05212377
TRx0237
Lecanemab
BMS-986368
KarX

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

14 of 24 total trials

A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD

The goal of this clinical trial is to learn if buntanetap/Posiphen works to treat early Alzheimer's disease in adults aged 55-85. It will also learn...

Enrolling
Early Alzheimers Disease
Drug: buntanetap/posiphen
Drug: Placebo

This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will...

Enrolling
Deep Brain Stimulation
Parkinson's Disease (PD)
Drug: buntanetap/posiphen

This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptom...

Active, not recruiting
Alzheimer's Disease
Mental Disorders
Drug: Dexamethasone
Drug: Placebo

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The primary objective of the study is to determine the dose response of E2814, when concurrently administered with lecanemab, on the change from base...

Active, not recruiting
Alzheimer's Disease
Drug: E2814
Drug: Lecanemab

This is a Phase 2, double-blind, parallel-group, placebo-controlled study to assess safety, tolerability, pharmacokinetics, and efficacy of ONO-2020...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: ONO-2020

The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's...

Active, not recruiting
Alzheimer's Disease
Drug: Placebo
Drug: Remternetug

The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early symptomatic A...

Active, not recruiting
Alzheimer's Disease
Drug: Remternetug (SC)
Drug: Placebo

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Lecanemab SC
Drug: Placebo

The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

Enrolling
Alzheimer's Disease
Other: Placebo
Drug: KarXT

The goal of this clinical trial is to learn how integrating health and wellness coaching (HWC) with Continuous Positive Airway Pressure (CPAP) therap...

Active, not recruiting
Obstructive Sleep Apnea
Behavioral: STANDARDCARE (STAND) group
Other: CONTROL (CON) group

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: AR1001

Randomized efficacy and safety study of piromelatine 20 mg versus placebo in participants with mild dementia due to Alzheimer's disease (AD) who are...

Active, not recruiting
Alzheimer's Disease
Drug: Piromelatine 20 mg
Drug: Placebo

This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participan...

Enrolling
Alzheimer Disease
Agitation
Drug: Placebo
Drug: BMS-986368

Trial sponsors

Lilly logo
A
Eisai logo
T
A
Bristol-Myers Squibb (BMS) logo
Celgene logo
C
Genzyme logo
H

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems